A Clinical Trial of a Recombinant Adenovirus 5 Vectored COVID-19 Vaccine (Ad5-nCoV) With Two Doses in Healthy Adults
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04552366 |
Recruitment Status : Unknown
Verified September 2020 by Institute of Biotechnology, Academy of Military Medical Sciences, PLA of China.
Recruitment status was: Active, not recruiting
First Posted : September 17, 2020
Last Update Posted : December 7, 2020
|
Sponsor:
Institute of Biotechnology, Academy of Military Medical Sciences, PLA of China
Collaborator:
Zhongnan Hospital
Information provided by (Responsible Party):
Institute of Biotechnology, Academy of Military Medical Sciences, PLA of China
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Unknown |
---|---|
Estimated Primary Completion Date : | December 31, 2020 |
Estimated Study Completion Date : | June 30, 2021 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):